1 Ustekinumab Market Overview 1.1 Ustekinumab Product Overview 1.2 Ustekinumab Market Segment by Type 1.2.1 Intravenous 1.2.2 Subcutaneous 1.3 Global Ustekinumab Market Size by Type 1.3.1 Global Ustekinumab Market Size Overview by Type (2016-2027) 1.3.2 Global Ustekinumab Historic Market Size Review by Type (2016-2021) 1.3.2.1 Global Ustekinumab Sales Breakdown in Volume by Type (2016-2021) 1.3.2.2 Global Ustekinumab Sales Breakdown in Value by Type (2016-2021) 1.3.2.3 Global Ustekinumab Average Selling Price (ASP) by Type (2016-2021) 1.3.3 Global Ustekinumab Forecasted Market Size by Type (2022-2027) 1.3.3.1 Global Ustekinumab Sales Breakdown in Volume by Type (2022-2027) 1.3.3.2 Global Ustekinumab Sales Breakdown in Value by Type (2022-2027) 1.3.3.3 Global Ustekinumab Average Selling Price (ASP) by Type (2022-2027) 1.4 Key Regions Market Size Segment by Type 1.4.1 North America Ustekinumab Sales Breakdown by Type (2016-2021) 1.4.2 Europe Ustekinumab Sales Breakdown by Type (2016-2021) 1.4.3 Asia-Pacific Ustekinumab Sales Breakdown by Type (2016-2021) 1.4.4 Latin America Ustekinumab Sales Breakdown by Type (2016-2021) 1.4.5 Middle East and Africa Ustekinumab Sales Breakdown by Type (2016-2021) 2 Global Ustekinumab Market Competition by Company 2.1 Global Top Players by Ustekinumab Sales (2016-2021) 2.2 Global Top Players by Ustekinumab Revenue (2016-2021) 2.3 Global Top Players Ustekinumab Price (2016-2021) 2.4 Global Top Manufacturers Ustekinumab Manufacturing Base Distribution, Sales Area, Product Type 2.5 Ustekinumab Market Competitive Situation and Trends 2.5.1 Ustekinumab Market Concentration Rate (2016-2021) 2.5.2 Global 5 and 10 Largest Manufacturers by Ustekinumab Sales and Revenue in 2020 2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Ustekinumab as of 2020) 2.7 Date of Key Manufacturers Enter into Ustekinumab Market 2.8 Key Manufacturers Ustekinumab Product Offered 2.9 Mergers & Acquisitions, Expansion 3 Ustekinumab Status and Outlook by Region 3.1 Global Ustekinumab Market Size and CAGR by Region: 2016 VS 2021 VS 2026 3.2 Global Ustekinumab Historic Market Size by Region 3.2.1 Global Ustekinumab Sales in Volume by Region (2016-2021) 3.2.2 Global Ustekinumab Sales in Value by Region (2016-2021) 3.2.3 Global Ustekinumab Sales (Volume & Value) Price and Gross Margin (2016-2021) 3.3 Global Ustekinumab Forecasted Market Size by Region 3.3.1 Global Ustekinumab Sales in Volume by Region (2022-2027) 3.3.2 Global Ustekinumab Sales in Value by Region (2022-2027) 3.3.3 Global Ustekinumab Sales (Volume & Value), Price and Gross Margin (2022-2027) 4 Global Ustekinumab by Application 4.1 Ustekinumab Market Segment by Application 4.1.1 Arthritis 4.1.2 Colitis 4.1.3 Lupus Erythematosus 4.1.4 Myositis Multiplex With Palmoplantar Pustulosis 4.1.5 Cirrhosis Of The Liver 4.1.6 Sarcoidosis 4.1.7 Diabetes 4.1.8 Other 4.2 Global Ustekinumab Market Size by Application 4.2.1 Global Ustekinumab Market Size Overview by Application (2016-2027) 4.2.2 Global Ustekinumab Historic Market Size Review by Application (2016-2021) 4.2.2.1 Global Ustekinumab Sales Breakdown in Volume, by Application (2016-2021) 4.2.2.2 Global Ustekinumab Sales Breakdown in Value, by Application (2016-2021) 4.2.2.3 Global Ustekinumab Average Selling Price (ASP) by Application (2016-2021) 4.2.3 Global Ustekinumab Forecasted Market Size by Application (2022-2027) 4.2.3.1 Global Ustekinumab Sales Breakdown in Volume, by Application (2022-2027) 4.2.3.2 Global Ustekinumab Sales Breakdown in Value, by Application (2022-2027) 4.2.3.3 Global Ustekinumab Average Selling Price (ASP) by Application (2022-2027) 4.3 Key Regions Market Size Segment by Application 4.3.1 North America Ustekinumab Sales Breakdown by Application (2016-2021) 4.3.2 Europe Ustekinumab Sales Breakdown by Application (2016-2021) 4.3.3 Asia-Pacific Ustekinumab Sales Breakdown by Application (2016-2021) 4.3.4 Latin America Ustekinumab Sales Breakdown by Application (2016-2021) 4.3.5 Middle East and Africa Ustekinumab Sales Breakdown by Application (2016-2021) 5 North America Ustekinumab by Country 5.1 North America Ustekinumab Historic Market Size by Country 5.1.1 North America Ustekinumab Sales in Volume by Country (2016-2021) 5.1.2 North America Ustekinumab Sales in Value by Country (2016-2021) 5.2 North America Ustekinumab Forecasted Market Size by Country 5.2.1 North America Ustekinumab Sales in Volume by Country (2022-2027) 5.2.2 North America Ustekinumab Sales in Value by Country (2022-2027) 6 Europe Ustekinumab by Country 6.1 Europe Ustekinumab Historic Market Size by Country 6.1.1 Europe Ustekinumab Sales in Volume by Country (2016-2021) 6.1.2 Europe Ustekinumab Sales in Value by Country (2016-2021) 6.2 Europe Ustekinumab Forecasted Market Size by Country 6.2.1 Europe Ustekinumab Sales in Volume by Country (2022-2027) 6.2.2 Europe Ustekinumab Sales in Value by Country (2022-2027) 7 Asia-Pacific Ustekinumab by Region 7.1 Asia-Pacific Ustekinumab Historic Market Size by Region 7.1.1 Asia-Pacific Ustekinumab Sales in Volume by Region (2016-2021) 7.1.2 Asia-Pacific Ustekinumab Sales in Value by Region (2016-2021) 7.2 Asia-Pacific Ustekinumab Forecasted Market Size by Region 7.2.1 Asia-Pacific Ustekinumab Sales in Volume by Region (2022-2027) 7.2.2 Asia-Pacific Ustekinumab Sales in Value by Region (2022-2027) 8 Latin America Ustekinumab by Country 8.1 Latin America Ustekinumab Historic Market Size by Country 8.1.1 Latin America Ustekinumab Sales in Volume by Country (2016-2021) 8.1.2 Latin America Ustekinumab Sales in Value by Country (2016-2021) 8.2 Latin America Ustekinumab Forecasted Market Size by Country 8.2.1 Latin America Ustekinumab Sales in Volume by Country (2022-2027) 8.2.2 Latin America Ustekinumab Sales in Value by Country (2022-2027) 9 Middle East and Africa Ustekinumab by Country 9.1 Middle East and Africa Ustekinumab Historic Market Size by Country 9.1.1 Middle East and Africa Ustekinumab Sales in Volume by Country (2016-2021) 9.1.2 Middle East and Africa Ustekinumab Sales in Value by Country (2016-2021) 9.2 Middle East and Africa Ustekinumab Forecasted Market Size by Country 9.2.1 Middle East and Africa Ustekinumab Sales in Volume by Country (2022-2027) 9.2.2 Middle East and Africa Ustekinumab Sales in Value by Country (2022-2027) 10 Company Profiles and Key Figures in Ustekinumab Business 10.1 Meiji 10.1.1 Meiji Corporation Information 10.1.2 Meiji Introduction and Business Overview 10.1.3 Meiji Ustekinumab Sales, Revenue and Gross Margin (2016-2021) 10.1.4 Meiji Ustekinumab Products Offered 10.1.5 Meiji Recent Development 10.2 Johnson & Johnson 10.2.1 Johnson & Johnson Corporation Information 10.2.2 Johnson & Johnson Introduction and Business Overview 10.2.3 Johnson & Johnson Ustekinumab Sales, Revenue and Gross Margin (2016-2021) 10.2.4 Meiji Ustekinumab Products Offered 10.2.5 Johnson & Johnson Recent Development 10.3 Alvotech 10.3.1 Alvotech Corporation Information 10.3.2 Alvotech Introduction and Business Overview 10.3.3 Alvotech Ustekinumab Sales, Revenue and Gross Margin (2016-2021) 10.3.4 Alvotech Ustekinumab Products Offered 10.3.5 Alvotech Recent Development 10.4 Fuji Pharma 10.4.1 Fuji Pharma Corporation Information 10.4.2 Fuji Pharma Introduction and Business Overview 10.4.3 Fuji Pharma Ustekinumab Sales, Revenue and Gross Margin (2016-2021) 10.4.4 Fuji Pharma Ustekinumab Products Offered 10.4.5 Fuji Pharma Recent Development 10.5 Mitsubishi Tanabe 10.5.1 Mitsubishi Tanabe Corporation Information 10.5.2 Mitsubishi Tanabe Introduction and Business Overview 10.5.3 Mitsubishi Tanabe Ustekinumab Sales, Revenue and Gross Margin (2016-2021) 10.5.4 Mitsubishi Tanabe Ustekinumab Products Offered 10.5.5 Mitsubishi Tanabe Recent Development 10.6 Stada 10.6.1 Stada Corporation Information 10.6.2 Stada Introduction and Business Overview 10.6.3 Stada Ustekinumab Sales, Revenue and Gross Margin (2016-2021) 10.6.4 Stada Ustekinumab Products Offered 10.6.5 Stada Recent Development 10.7 EPIRUS BioPharma 10.7.1 EPIRUS BioPharma Corporation Information 10.7.2 EPIRUS BioPharma Introduction and Business Overview 10.7.3 EPIRUS BioPharma Ustekinumab Sales, Revenue and Gross Margin (2016-2021) 10.7.4 EPIRUS BioPharma Ustekinumab Products Offered 10.7.5 EPIRUS BioPharma Recent Development 10.8 Formycon 10.8.1 Formycon Corporation Information 10.8.2 Formycon Introduction and Business Overview 10.8.3 Formycon Ustekinumab Sales, Revenue and Gross Margin (2016-2021) 10.8.4 Formycon Ustekinumab Products Offered 10.8.5 Formycon Recent Development 10.9 NeuClone 10.9.1 NeuClone Corporation Information 10.9.2 NeuClone Introduction and Business Overview 10.9.3 NeuClone Ustekinumab Sales, Revenue and Gross Margin (2016-2021) 10.9.4 NeuClone Ustekinumab Products Offered 10.9.5 NeuClone Recent Development 10.10 Outlook Therapeutics 10.10.1 Company Basic Information, Manufacturing Base and Competitors 10.10.2 Ustekinumab Product Category, Application and Specification 10.10.3 Outlook Therapeutics Ustekinumab Sales, Revenue, Price and Gross Margin (2016-2021) 10.10.4 Main Business Overview 10.10.5 Outlook Therapeutics Recent Development 10.11 Harvest Moon Pharma 10.11.1 Harvest Moon Pharma Corporation Information 10.11.2 Harvest Moon Pharma Introduction and Business Overview 10.11.3 Harvest Moon Pharma Ustekinumab Sales, Revenue and Gross Margin (2016-2021) 10.11.4 Harvest Moon Pharma Ustekinumab Products Offered 10.11.5 Harvest Moon Pharma Recent Development 10.12 BioXpress 10.12.1 BioXpress Corporation Information 10.12.2 BioXpress Introduction and Business Overview 10.12.3 BioXpress Ustekinumab Sales, Revenue and Gross Margin (2016-2021) 10.12.4 BioXpress Ustekinumab Products Offered 10.12.5 BioXpress Recent Development 11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis 11.1 Ustekinumab Key Raw Materials 11.1.1 Key Raw Materials 11.1.2 Key Raw Materials Price 11.1.3 Raw Materials Key Suppliers 11.2 Manufacturing Cost Structure 11.2.1 Raw Materials 11.2.2 Labor Cost 11.2.3 Manufacturing Expenses 11.3 Ustekinumab Industrial Chain Analysis 11.4 Ustekinumab Market Dynamics 11.4.1 Industry Trends 11.4.2 Market Drivers 11.4.3 Market Challenges 11.4.4 Market Restraints 12 Market Strategy Analysis, Distributors 12.1 Sales Channel 12.2 Ustekinumab Distributors 12.3 Ustekinumab Downstream Customers 13 Research Findings and Conclusion 14 Appendix 14.1 Research Methodology 14.1.1 Methodology/Research Approach 14.1.1.1 Research Programs/Design 14.1.1.2 Market Size Estimation 14.1.1.3 Market Breakdown and Data Triangulation 14.1.2 Data Source 14.1.2.1 Secondary Sources 14.1.2.2 Primary Sources 14.2 Author Details 14.3 Disclaimer

List of Tables Table 1. Major Company of Intravenous Table 2. Major Company of Subcutaneous Table 3. Global Ustekinumab Sales by Type 2016 VS 2021 VS 2027 (US$ Million) Table 4. Global Ustekinumab Sales by Type (2016-2021) & (K Units) Table 5. Global Ustekinumab Sales Market Share in Volume by Type (2016-2021) Table 6. Global Ustekinumab Sales by Type (2016-2021) & (US& Million) Table 7. Global Ustekinumab Market Share in Value by Type (2016-2021) Table 8. Global Ustekinumab Price by Type (2016-2021) & (US$/Unit) Table 9. Global Ustekinumab Sales by Type (2022-2027) & (K Units) Table 10. Global Ustekinumab Sales Market Share in Volume by Type (2022-2027) Table 11. Global Ustekinumab Sales by Type (2022-2027) & (US$ Million) Table 12. Global Ustekinumab Sales Market Share in Value by Type (2022-2027) Table 13. Global Ustekinumab Price by Type (2022-2027) & (US$/Unit) Table 14. North America Ustekinumab Sales by Type (2016-2021) & (K Units) Table 15. North America Ustekinumab Sales by Type (2016-2021) & (US$ Million) Table 16. Europe Ustekinumab Sales (K Units) by Type (2016-2021) Table 17. Europe Ustekinumab Sales by Type (2016-2021) & (US$ Million) Table 18. Asia-Pacific Ustekinumab Sales (K Units) by Type (2016-2021) Table 19. Asia-Pacific Ustekinumab Sales by Type (2016-2021) & (US$ Million) Table 20. Latin America Ustekinumab Sales (K Units) by Type (2016-2021) Table 21. Latin America Ustekinumab Sales by Type (2016-2021) & (US$ Million) Table 22. Middle East and Africa Ustekinumab Sales (K Units) by Type (2016-2021) Table 23. Middle East and Africa Ustekinumab Sales by Type (2016-2021) & (US$ Million) Table 24. Global Ustekinumab Sales by Company (2016-2021) & (K Units) Table 25. Global Ustekinumab Sales Share by Company (2016-2021) Table 26. Global Ustekinumab Revenue by Company (2016-2021) & (US$ Million) Table 27. Global Ustekinumab Revenue Share by Company (2016-2021) Table 28. Global Market Ustekinumab Price by Company (2016-2021) & (US$/Unit) Table 29. Global Ustekinumab Top Manufacturers Manufacturing Base Distribution and Sales Area Table 30. Global Ustekinumab Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Ustekinumab as of 2020 Table 32. Date of Key Manufacturers Enter into Ustekinumab Market Table 33. Key Manufacturers Ustekinumab Product Type Table 34. Mergers & Acquisitions, Expansion Plans Table 35. Global Ustekinumab Market Size Comparison by Region (US$ Million): 2016 VS 2021 VS 2027 Table 36. Global Ustekinumab Sales by Region (2016-2021) & (K Units) Table 37. Global Ustekinumab Sales Market Share in Volume by Region (2016-2021) Table 38. Global Ustekinumab Sales by Region (2016-2021) & (US$ Million) Table 39. Global Ustekinumab Sales Market Share in Value by Region (2016-2021) Table 40. Global Ustekinumab Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 41. Global Ustekinumab Sales by Region (2022-2027) & (K Units) Table 42. Global Ustekinumab Sales Market Share in Volume by Region (2022-2027) Table 43. Global Ustekinumab Sales by Region (2022-2027) & (US$ Million) Table 44. Global Ustekinumab Sales Market Share in Value by Region (2022-2027) Table 45. Global Ustekinumab Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2022-2027) Table 46. Global Ustekinumab Sales by Application: 2016 VS 2021 VS 2027 (US$ Million) Table 47. Global Ustekinumab Sales by Application (2016-2021) & (K Units) Table 48. Global Ustekinumab Sales Market Share in Volume by Application (2016-2021) Table 49. Global Ustekinumab Sales by Application (2016-2021) & (US$ Million) Table 50. Global Ustekinumab Sales Market Share in Value by Application (2016-2021) Table 51. Global Ustekinumab Price by Application (2016-2021) & (US$/Unit) Table 52. Global Ustekinumab Sales by Application (2022-2027) & (K Units) Table 53. Global Ustekinumab Sales Market Share in Volume by Application (2022-2027) Table 54. Global Ustekinumab Sales by Application (2022-2027) & (US$ Million) Table 55. Global Ustekinumab Sales Market Share in Value by Application (2022-2027) Table 56. Global Ustekinumab Price by Application (2022-2027) & (US$/Unit) Table 57. North America Ustekinumab Sales by Application (2016-2021) (K Units) Table 58. North America Ustekinumab Sales by Application (2016-2021) & (US$ Million) Table 59. North America Ustekinumab Sales Market Share in Value by Application in 2020 Table 60. Europe Ustekinumab Sales by Application (2016-2021) (K Units) Table 61. Europe Ustekinumab Sales by Application (2016-2021) & (US$ Million) Table 62. Europe Ustekinumab Sales Market Share in Value by Application in 2020 Table 63. Asia-Pacific Ustekinumab Sales by Application (2016-2021) (K Units) Table 64. Asia-Pacific Ustekinumab Sales by Application (2016-2021) & (US$ Million) Table 65. Asia-Pacific Ustekinumab Sales Market Share in Value by Application in 2020 Table 66. Latin America Ustekinumab Sales by Application (2016-2021) (K Units) Table 67. Latin America Ustekinumab Sales by Application (2016-2021) & (US$ Million) Table 68. Latin America Ustekinumab Sales Market Share in Value by Application in 2020 Table 69. Middle East and Africa Ustekinumab Sales by Application (2016-2021) (K Units) Table 70. Middle East and Africa Ustekinumab Sales by Application (2016-2021) & (US$ Million) Table 71. Middle East and Africa Ustekinumab Sales Market Share in Value by Application in 2020 Table 72. North America Ustekinumab Sales by Country (2016-2021) & (K Units) Table 73. North America Ustekinumab Sales Market Share in Volume by Country (2016-2021) Table 74. North America Ustekinumab Sales by Country (2016-2021) & (US$ Million) Table 75. North America Ustekinumab Sales Market Share in Value by Country (2016-2021) Table 76. North America Ustekinumab Sales by Country (2022-2027) & (K Units) Table 77. North America Ustekinumab Sales Market Share in Volume by Country (2022-2027) Table 78. North America Ustekinumab Sales by Country (2022-2027) & (US$ Million) Table 79. North America Ustekinumab Sales Market Share in Value by Country (2022-2027) Table 80. Europe Ustekinumab Sales by Country (2016-2021) & (K Units) Table 81. Europe Ustekinumab Sales Market Share in Volume by Country (2016-2021) Table 82. Europe Ustekinumab Sales by Country (2016-2021) & (US$ Million) Table 83. Europe Ustekinumab Sales Market Share in Value by Country (2016-2021) Table 84. Europe Ustekinumab Sales by Country (2022-2027) & (K Units) Table 85. Europe Ustekinumab Sales Market Share in Volume by Country (2022-2027) Table 86. Europe Ustekinumab Sales by Country (2022-2027) & (US$ Million) Table 87. Europe Ustekinumab Sales Market Share in Value by Country (2022-2027) Table 88. Asia-Pacific Ustekinumab Sales by Region (2016-2021) & (K Units) Table 89. Asia-Pacific Ustekinumab Sales Market Share in Volume by Region (2016-2021) Table 90. Asia-Pacific Ustekinumab Sales by Region (2016-2021) & (US$ Million) Table 91. Asia-Pacific Ustekinumab Sales Market Share in Value by Region (2016-2021) Table 92. Asia-Pacific Ustekinumab Sales by Region (2022-2027) & (K Units) Table 93. Asia-Pacific Ustekinumab Sales Market Share in Volume by Region (2022-2027) Table 94. Asia-Pacific Ustekinumab Sales by Region (2022-2027) & (US$ Million) Table 95. Asia-Pacific Ustekinumab Sales Market Share in Value by Region (2022-2027) Table 96. Latin America Ustekinumab Sales by Country (2016-2021) & (K Units) Table 97. Latin America Ustekinumab Sales Market Share in Volume by Country (2016-2021) Table 98. Latin America Ustekinumab Sales by Country (2016-2021) & (US$ Million) Table 99. Latin America Ustekinumab Sales Market Share in Value by Country (2016-2021) Table 100. Latin America Ustekinumab Sales by Country (2022-2027) & (K Units) Table 101. Latin America Ustekinumab Sales Market Share in Volume by Country (2022-2027) Table 102. Latin America Ustekinumab Sales by Country (2022-2027) & (US$ Million) Table 103. Latin America Ustekinumab Sales Market Share in Value by Country (2022-2027) Table 104. Middle East and Africa Ustekinumab Sales by Country (2016-2021) & (K Units) Table 105. Middle East and Africa Ustekinumab Sales Market Share in Volume by Country (2016-2021) Table 106. Middle East and Africa Ustekinumab Sales by Country (2016-2021) & (US$ Million) Table 107. Middle East and Africa Ustekinumab Sales Market Share in Value by Country (2016-2021) Table 108. Middle East and Africa Ustekinumab Sales by Country (2022-2027) & (K Units) Table 109. Middle East and Africa Ustekinumab Sales Market Share in Volume by Country (2022-2027) Table 110. Middle East and Africa Ustekinumab Sales by Country (2022-2027) & (US$ Million) Table 111. Middle East and Africa Ustekinumab Sales Market Share in Value by Country (2022-2027) Table 112. Meiji Corporation Information Table 113. Meiji Introduction and Business Overview Table 114. Meiji Ustekinumab Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 115. Meiji Ustekinumab Product Table 116. Meiji Recent Development Table 117. Johnson & Johnson Corporation Information Table 118. Johnson & Johnson Introduction and Business Overview Table 119. Johnson & Johnson Ustekinumab Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 120. Johnson & Johnson Ustekinumab Product Table 121. Johnson & Johnson Recent Development Table 122. Alvotech Corporation Information Table 123. Alvotech Introduction and Business Overview Table 124. Alvotech Ustekinumab Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 125. Alvotech Ustekinumab Product Table 126. Alvotech Recent Development Table 127. Fuji Pharma Corporation Information Table 128. Fuji Pharma Introduction and Business Overview Table 129. Fuji Pharma Ustekinumab Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 130. Fuji Pharma Ustekinumab Product Table 131. Fuji Pharma Recent Development Table 132. Mitsubishi Tanabe Corporation Information Table 133. Mitsubishi Tanabe Introduction and Business Overview Table 134. Mitsubishi Tanabe Ustekinumab Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 135. Mitsubishi Tanabe Ustekinumab Product Table 136. Mitsubishi Tanabe Recent Development Table 137. Stada Corporation Information Table 138. Stada Introduction and Business Overview Table 139. Stada Ustekinumab Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 140. Stada Ustekinumab Product Table 141. Stada Recent Development Table 142. EPIRUS BioPharma Corporation Information Table 143. EPIRUS BioPharma Introduction and Business Overview Table 144. EPIRUS BioPharma Ustekinumab Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 145. EPIRUS BioPharma Ustekinumab Product Table 146. EPIRUS BioPharma Recent Development Table 147. Formycon Corporation Information Table 148. Formycon Introduction and Business Overview Table 149. Formycon Ustekinumab Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 150. Formycon Ustekinumab Product Table 151. Formycon Recent Development Table 152. NeuClone Corporation Information Table 153. NeuClone Introduction and Business Overview Table 154. NeuClone Ustekinumab Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 155. NeuClone Ustekinumab Product Table 156. NeuClone Recent Development Table 157. Outlook Therapeutics Corporation Information Table 158. Outlook Therapeutics Introduction and Business Overview Table 159. Outlook Therapeutics Ustekinumab Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 160. Outlook Therapeutics Ustekinumab Product Table 161. Outlook Therapeutics Recent Development Table 162. Harvest Moon Pharma Corporation Information Table 163. Harvest Moon Pharma Introduction and Business Overview Table 164. Harvest Moon Pharma Ustekinumab Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 165. Harvest Moon Pharma Ustekinumab Product Table 166. Harvest Moon Pharma Recent Development Table 167. BioXpress Corporation Information Table 168. BioXpress Introduction and Business Overview Table 169. BioXpress Ustekinumab Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 170. BioXpress Ustekinumab Product Table 171. BioXpress Recent Development Table 172. Key Raw Materials Lists Table 173. Raw Materials Key Suppliers Lists Table 174. Ustekinumab Market Trends Table 175. Ustekinumab Market Drivers Table 176. Ustekinumab Market Challenges Table 177. Ustekinumab Market Restraints Table 178. Ustekinumab Distributors List Table 179. Ustekinumab Downstream Customers Table 180. Research Programs/Design for This Report Table 181. Key Data Information from Secondary Sources Table 182. Key Data Information from Primary Sources List of Figures Figure 1. Ustekinumab Product Picture Figure 2. Global Ustekinumab Market Size, 2016 VS 2021 VS 2027 (US$ Million) Figure 3. Global Ustekinumab Market Size Status and Outlook (2016-2027) & (US$ Million) Figure 4. Global Ustekinumab Sales Status and Outlook (2016-2027) & (K Units) Figure 5. Product Picture of Intravenous Figure 6. Global Intravenous Sales YoY Growth (2016-2021) & (K Units) Figure 7. Product Picture of Subcutaneous Figure 8. Global Subcutaneous Sales YoY Growth (2016-2021) & (K Units) Figure 9. Global Ustekinumab Sales by Type (2016-2027) & (US$ Million) Figure 10. Global Ustekinumab Sales Market Share in Volume by Type (2016-2021) Figure 11. Global Ustekinumab Sales Market Share in Value by Type (2016-2021) Figure 12. Global Ustekinumab Sales Market Share in Volume by Type (2022-2027) Figure 13. Global Ustekinumab Sales Market Share in Value by Type (2022-2027) Figure 14. North America Ustekinumab Sales Market Share in Volume by Type in 2020 Figure 15. North America Ustekinumab Sales Market Share in Value by Type in 2020 Figure 16. Europe Ustekinumab Sales Market Share in Volume by Type in 2020 Figure 17. Europe Ustekinumab Sales Market Share in Value by Type in 2020 Figure 18. Asia-Pacific Ustekinumab Sales Market Share in Volume by Type in 2020 Figure 19. Asia-Pacific Ustekinumab Sales Market Share in Value by Type in 2020 Figure 20. Latin America Ustekinumab Sales Market Share in Volume by Type in 2020 Figure 21. Latin America Ustekinumab Sales Market Share in Value by Type in 2020 Figure 22. Middle East and Africa Ustekinumab Sales Market Share in Volume by Type in 2020 Figure 23. Middle East and Africa Ustekinumab Sales Market Share in Value by Type in 2020 Figure 24. The 5 and 10 Largest Manufacturers in the World: Market Share by Ustekinumab Sales in 2020 Figure 25. The 5 and 10 Largest Manufacturers in the World: Market Share by Ustekinumab Revenue in 2020 Figure 26. Ustekinumab Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020 Figure 27. Product Picture of Arthritis Figure 28. Global Arthritis Sales YoY Growth (2016-2027) & (K Units) Figure 29. Product Picture of Colitis Figure 30. Global Colitis Sales YoY Growth (2016-2027) & (K Units) Figure 31. Product Picture of Lupus Erythematosus Figure 32. Global Lupus Erythematosus Sales YoY Growth (2016-2027) & (K Units) Figure 33. Product Picture of Myositis Multiplex With Palmoplantar Pustulosis Figure 34. Global Myositis Multiplex With Palmoplantar Pustulosis Sales YoY Growth (2016-2027) & (K Units) Figure 35. Product Picture of Cirrhosis Of The Liver Figure 36. Global Cirrhosis Of The Liver Sales YoY Growth (2016-2027) & (K Units) Figure 37. Product Picture of Sarcoidosis Figure 38. Global Sarcoidosis Sales YoY Growth (2016-2027) & (K Units) Figure 39. Product Picture of Diabetes Figure 40. Global Diabetes Sales YoY Growth (2016-2027) & (K Units) Figure 41. Product Picture of Other Figure 42. Global Other Sales YoY Growth (2016-2027) & (K Units) Figure 43. Global Ustekinumab Sales by Application (2016-2027) & (US$ Million) Figure 44. Global Ustekinumab Sales Market Share in Volume by Application (2016-2021) Figure 45. Global Ustekinumab Sales Market Share in Value by Application (2016-2021) Figure 46. Global Ustekinumab Sales Market Share in Volume by Application (2022-2027) Figure 47. North America Ustekinumab Sales Market Share in Volume by Application in 2020 Figure 48. Latin America Ustekinumab Sales Market Share in Value by Application in 2020 Figure 49. Middle East and Africa Ustekinumab Sales Market Share in Value by Application in 2020 Figure 50. Key Raw Materials Price Figure 51. Ustekinumab Manufacturing Cost Structure Figure 52. Ustekinumab Industrial Chain Analysis Figure 53. Channels of Distribution Figure 54. Distributors Profiles Figure 55. Bottom-up and Top-down Approaches for This Report Figure 56. Data Triangulation Figure 57. Key Executives Interviewed

Meiji Johnson & Johnson Alvotech Fuji Pharma Mitsubishi Tanabe Stada EPIRUS BioPharma Formycon NeuClone Outlook Therapeutics Harvest Moon Pharma BioXpress